The Galien Foundation Announces Inaugural Webcast Of The Galien Forum
NEW YORK, Oct. 1, 2014 /PRNewswire/ -- The Galien Foundation announced today that the Fifth Annual Galien Forum will be streamed via a live webcast. The Galien Forum, conducted in conjunction with the prestigious Prix Galien USA Awards, features roundtable discussion on the most critical, global healthcare issues and challenges.
Register to attend the forum in-person or sign-up to view the live webcast by choosing "package I" at http://www.galienfoundation.org/en/rsystem/product-choose. The cost to stream the full webcast will be $75.00 for registration in advance, or $125 for registration after October 25th. The forum will take place on October 28th from 7:00 AM ET 5:00 PM ET.
This year the program will be comprised of six featured panels: "Heart Attack Guidelines," "Cancer Immuno Therapeutics," "US Health Reform," "The Brain Initiative," "New Agenda for Global Health" and "The Future of Digital Health."
In addition, the 2014 Galien Forum will feature a debate on "The Role of Innovation and Entrepreneurship in Cancer Research," and a Keynote Address by Cori Bargmann, Ph.D., The Rockefeller University, New York.
"We have another impressive program of Nobel Laureates and biomedical innovators this year," remarked Bruno Cohen, Chairman of the Galien Foundation. "In keeping with our mission to foster global health innovation, it is particularly exciting this year to be able to share the 2014 Galien Forum globally through our inaugural webcast."
About the Galien Foundation
The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.
The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in France in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.
For more information visit www.galienfoundation.org.
Galien Foundation Media Contact:
Bryan Gibbs
Makovsky on behalf of The Galien Foundation
bgibbs@makovsky.com
212 508 9676
Logo - http://photos.prnewswire.com/prnh/20140930/149467
SOURCE Galien Foundation